Steven Cohen Abbott Laboratories Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Abbott Laboratories stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 177,000 shares of ABT stock, worth $20.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
177,000
Previous 20,400
767.65%
Holding current value
$20.2 Million
Previous $2.12 Million
852.29%
% of portfolio
0.06%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...